Skip to main content
Equibles

Maha Radhakrishnan, M.D.

Board Member

Alto Neuroscience, Inc. (ANRO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Alto Neuroscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get ANRO alerts

About Maha Radhakrishnan, M.D.

Maha Radhakrishnan, M.D. is recorded as Board Member at Alto Neuroscience, Inc. (ANRO) since March 8, 2024. Alto Neuroscience, Inc. reported in an 8-K filed March 11, 2024 that Maha Radhakrishnan, M.D. was appointed member of the Board and as a member of the NCGC, effective March 8, 2024. Alto Neuroscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alto Neuroscience, Inc. includes Amit Etkin (CEO and Board Member), Nicholas Smith (CFO), Michael Hanley (COO) and 7 others.

“On March 8, 2024, the Board of Directors (the "Board") of Alto Neuroscience, Inc. (the "Company"), following the recommendation of the Nominating and Corporate Governance Committee of the Board (the "NCGC"), appointed Maha Radhakrishnan, M.D., to serve as a member of the Board and as a member of the NCGC.”
Alto Neuroscience, Inc. Form 8-K, filed March 11, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Alto Neuroscience, Inc.

Recent activity